Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

Introduction<p>T cell receptor-engineered T cell therapy has emerged as a promising approach in cancer immunotherapy, leveraging the ability of T cells to recognize tumor antigens presented on major histocompatibility complex molecules, offering a targeted approach for treating cancers. This s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Saleh Alrhmoun (19193851) (author)
Altres autors: Roman Perik-Zavodskii (19193839) (author), Marina Fisher (19828437) (author), Julia Lopatnikova (4164058) (author), Olga Perik-Zavodskaia (19193842) (author), Julia Shevchenko (19193845) (author), Kirill Nazarov (19193854) (author), Julia Philippova (19828440) (author), Vasily Kurilin (19828443) (author), Olga Kichakova (22680860) (author), Evgenii Zavjalov (12230774) (author), Elena Golikova (472121) (author), Petr Timashev (10031740) (author), Petr Glybochko (13011754) (author), Sergey Sennikov (4164055) (author)
Publicat: 2025
Matèries:
Genetic Immunology
TCR-T cells
TCR-T
T cells
adoptive cell therapy
her2/neu
ErbB2
ScRNA-seq
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars